Social and Prognostic Inequalities in Patients Hospitalised for Cerebrovascular Accident (CVA) in Four Contrasting French Departments

Social and Prognostic Inequalities in Patients Hospitalised for Cerebrovascular Accident (CVA) in Four Contrasting French Departments: Côte d'Or, Martinique, Guadeloupe and French Guyana Analysis of Their Impact on Vascular Risk Factors and the Management of CVA

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01906463

Acronym

INDIA

Enrollment

1612

Registered

2013-07-24

Start date

2011-07-31

Completion date

2015-10-31

Last updated

2018-12-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Symptomatic CVA (de Novo CVA)

Brief summary

This study should also raise questions about the interest and feasibility of establishing a permanent registry of CVA in the Antilles and Guyana. Indeed in coming decades, the expected doubling of the population of persons aged over 60 years and the foreseeable changes in lifestyle will increase the burden of this disease, in particular since the region is marked by a high prevalence of arterial hypertension and diabetes and a high level of precarity. In addition, this study will provide epidemiological information on CVA, its risk factors and management, which are non-existent for the department of French Guyana where the health environment is manifestly insufficient. These data should make it possible to better evaluate the resources available and the healthcare needs in Guyana.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Pre- inclusion * Patients who have received information about the study (directly or via a person of trust), * Patients aged more than 18 years, * Patient hospitalised for a suspected first symptomatic CVA (whatever the mechanism), preceded or not by a transient ischemic attack (TIA), * Patients with a cerebral imaging examination (CT-scan and/or MRI), * in Guyana, suspicion of a first CVA according to WHO clinical criteria and who died before the authorised images for descriptive purposes, * Patients able to answer questions personally or through a parent or a person of trust. Definitive inclusion \- Patients with confirmed CVA diagnosed according to clinical criteria (WHO criteria) and imaging criteria.

Exclusion criteria

* \- Patients who refuse to take part in the study, * Patients with prior symptomatic CVA, * Patients without cerebral imaging (except in Guyana, for patients with suspected CVA who died before imaging), * Patients with another severe evolutive disease that could cause death in the weeks following the CVA, * Patients who cannot be contacted by telephone at 1 month.

Design outcomes

Primary

Measure	Time frame
Medical history	Baseline

Secondary

Measure	Time frame
Follow-up questionnaire: functional handicap, intercurrent hospitalisation, vital status	Month 6

Countries

France

Outcome results